Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J H van Tits

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Critical Reviews in Immunology|May 19, 2018
Tumor Necrosis Factor: Function, Release and ClearanceM H A Bemelmans, L J H van Tits, W A Buurman
The Netherlands Journal of Medicine|March 7, 2006
The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicineT M van Himbergen, L J H van Tits, M Roest, et al.
Archives of Internal Medicine|June 29, 2005
Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trialJane Durga, L J H van Tits, Evert G Schouten, et al.
Annals of Clinical Biochemistry|January 25, 2003
Stability studies of ubiquinol in plasmaM P C Hectors, L J H van Tits, Y B de Rijke, et al.
Atherosclerosis|July 12, 2005
Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemiaL J H van Tits, T M van Himbergen, H L M Lemmers, et al.
Journal of Internal Medicine|October 22, 2005
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemiaT M Himbergen, L J H van Tits, H A M Voorbij, et al.
Rheumatology International|December 17, 2009
Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control studyE F H van Bommel, L J H van Tits, E A van den Berg, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
European Journal of Clinical Investigation|April 28, 2007
Endothelial function in familial combined hyperlipidaemiaE Ter Avest, S Holewijn, L J H van Tits, et al.
The Netherlands Journal of Medicine|February 23, 2008
Cholesterol in end-stage renal disease: the good, the bad or the ugly?S H A Diepeveen, J F M Wetzels, H J G Bilo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Critical Reviews in Immunology|May 19, 2018
Tumor Necrosis Factor: Function, Release and ClearanceM H A Bemelmans, L J H van Tits, W A Buurman
The Netherlands Journal of Medicine|March 7, 2006
The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicineT M van Himbergen, L J H van Tits, M Roest, et al.
Archives of Internal Medicine|June 29, 2005
Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trialJane Durga, L J H van Tits, Evert G Schouten, et al.
Annals of Clinical Biochemistry|January 25, 2003
Stability studies of ubiquinol in plasmaM P C Hectors, L J H van Tits, Y B de Rijke, et al.
Atherosclerosis|July 12, 2005
Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemiaL J H van Tits, T M van Himbergen, H L M Lemmers, et al.
Journal of Internal Medicine|October 22, 2005
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemiaT M Himbergen, L J H van Tits, H A M Voorbij, et al.
Rheumatology International|December 17, 2009
Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control studyE F H van Bommel, L J H van Tits, E A van den Berg, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
European Journal of Clinical Investigation|April 28, 2007
Endothelial function in familial combined hyperlipidaemiaE Ter Avest, S Holewijn, L J H van Tits, et al.
The Netherlands Journal of Medicine|February 23, 2008
Cholesterol in end-stage renal disease: the good, the bad or the ugly?S H A Diepeveen, J F M Wetzels, H J G Bilo, et al.
Pageof 2